Doi.org/10.1210/jc.2015-1884
Revision as of 06:09, 18 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == SGLT2 Inhibitors May Predispose to Ketoacidosis ; Taylor, Simeon; et al.; The Journal of Clinical Endocrinology & Metabolism; 2015; https://doi.org/10.1210/jc.2015-1884 == Article providing comments == Letter to the Editor: Comment on “SGLT2 inhibitors may predispose to ketoacidosis” by Taylor S.I., et al; Segar, Lakshman; ; The Journal of Clinical Endocrinology & Metabolism; 2016-2-01 https://doi.org/10.1210/jc.2015-4236 == Summary == Note: Open...")
Target Article[edit | edit source]
SGLT2 Inhibitors May Predispose to Ketoacidosis ; Taylor, Simeon; et al.; The Journal of Clinical Endocrinology & Metabolism; 2015; https://doi.org/10.1210/jc.2015-1884
Article providing comments[edit | edit source]
Letter to the Editor: Comment on “SGLT2 inhibitors may predispose to ketoacidosis” by Taylor S.I., et al; Segar, Lakshman; ; The Journal of Clinical Endocrinology & Metabolism; 2016-2-01 https://doi.org/10.1210/jc.2015-4236
Summary[edit | edit source]
Note: Opened to append information.